GlassScriptPhysician profile
Brett Dempsey
NPI 1659599538
$483.63
in general payments reported to CMS, 2019-2025
12 companies · $53.77 in 2025
The $53.77 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $19.14 · 2021: $84.30 · 2022: $122 · 2024: $40.27 · 2025: $53.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prytime Medical Devices, INC. | $107.89 | 2022 | |
| Davol INC. | $95.92 | 2019 | |
| Intuitive Surgical, INC. | $72.24 | 2021 | |
| Boston Scientific Corporation | $46.08 | 2024-2025 | Advantage System, General - Vascular Intervention |
| Polynovo North America LLC | $31.75 | 2025 | Novosorb Btm |
| Ethicon US, LLC | $26.66 | 2019 | |
| Allergan, INC. | $24.74 | 2019-2021 | |
| Kci USA, INC. | $19.14 | 2020 | |
| Atricure, INC. | $16.21 | 2024 | |
| Convatec INC. | $15.15 | 2019 | |
| 180 Medical, INC. | $14.09 | 2019 | |
| Ucb, INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Dempsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.